Aug 2026· World Journal of Psychiatry· Vol 16· 0 citations· 46 references
TL;DR
Clinical evidence suggests that interventions targeting sleep, particularly cognitive behavioral therapy for insomnia and chronotherapeutic approaches, can reduce depressive symptoms and improve treatment outcomes when integrated into standard depression care.
Abstract
Sleep disturbance is one of the most common and clinically important features of depressive disorders. Although it has traditionally been viewed as a secondary symptom of depression, growing evidence indicates that sleep disturbance plays an active role in both the development and persistence of depressive illness. Longitudinal and experimental studies demonstrate that insomnia, poor sleep quality, and circadian rhythm disruption increase vulnerability to depression, are associated with greater symptom severity, and elevate the risk of relapse. Conversely, depressive disorders disrupt sleep regulation through characteristic changes in sleep architecture, circadian misalignment, and maladaptive sleep related behaviors, creating a self reinforcing cycle between sleep disturbance and mood dysregulation. Shared mechanisms underlying this bidirectional relationship include alterations in monoaminergic neurotransmission, hypothalamic pituitary adrenal axis activation, circadian rhythm disruption, inflammatory processes, and impaired emotional regulation. Clinical evidence further suggests that interventions targeting sleep, particularly cognitive behavioral therapy for insomnia and chronotherapeutic approaches, can reduce depressive symptoms and improve treatment outcomes when integrated into standard depression care. This narrative review synthesizes current evidence on the bidirectional relationship between sleep disturbance and depression and highlights its implications for clinical practice and future research.
Sleep disturbances are increasingly recognized as clinically relevant markers in the early detection of psychotic disorders among adolescents and young adults. These disturbances, including insomnia, circadian rhythm disruptions, parasomnias, and fragmented sleep, affect up to 70% of individuals at clinical high risk f...
Julia Jaromirska, D. Strzelecki, Magdalena Kotlicka-antczak et al.· Frontiers in Synaptic Neuros...· 0 citations
This review synthesises current evidence on sleep physiology, the neurobiological basis of sleep deprivation effects, specific cognitive and mood consequences, vulnerable populations, diagnostic approaches, therapeutic strategies, and public health implications, with the goal of providing a comprehensive foundation for...
Paweł Stępowski, Hanna Rzepka, Mateusz Tajster· Journal of Education, Health...· 0 citations
This review synthesizes findings from polysomnography, actigraphy, circadian rhythm research, neuroimaging, electrophysiological studies, and animal models to examine how E/I-related vulnerability in ASD may contribute to impaired sleep initiation and maintenance.
Yu-Han Wu, Di Wu, Wei Zhong et al.· ALPHA PSYCHIATRY· 0 citations
This chapter explores how sleep, anxiety, and depression interact from various scientific and clinical viewpoints, including circadian rhythms, stress hormones, immune signalling, genetic and environmental effects, cognitive impairments, developmental factors, and new treatment options.
Jayanth K. Rao, Lakshmi Sowmya Emani, Sejali Padhi et al.· Progress in Brain Research· 0 citations
Adolescent depression is a major global public health concern, and circadian rhythm research provides a new perspective for understanding adolescent depression vulnerability. The adolescent circadian system undergoes natural developmental remodeling characterized by physiological phase delay, which conflicts with rigid...
Ting-Yao Zhou· Lecture Notes in Education P...· 0 citations
A multidisciplinary approach integrating systematic screening for sleep disorders, optimization of antiseizure medication timing and selection, treatment of comorbid obstructive sleep apnea, and behavioral sleep interventions has the potential to meaningfully improve outcomes in patients with epilepsy.
Giulia Bellone, Martina Bonometti, Alice Rubeo et al.· Frontiers in Neurology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.